Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D–induced inhibition of bone mineralization
Open Access
- 1 May 2012
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 122 (5), 1803-1815
- https://doi.org/10.1172/jci45890
Abstract
Serum calcium levels are tightly controlled by an integrated hormone-controlled system that involves active vitamin D [1,25(OH)2D], which can elicit calcium mobilization from bone when intestinal calcium absorption is decreased. The skeletal adaptations, however, are still poorly characterized. To gain insight into these issues, we analyzed the consequences of specific vitamin D receptor (Vdr) inactivation in the intestine and in mature osteoblasts on calcium and bone homeostasis. We report here that decreased intestinal calcium absorption in intestine-specific Vdr knockout mice resulted in severely reduced skeletal calcium levels so as to ensure normal levels of calcium in the serum. Furthermore, increased 1,25(OH)2D levels not only stimulated bone turnover, leading to osteopenia, but also suppressed bone matrix mineralization. This resulted in extensive hyperosteoidosis, also surrounding the osteocytes, and hypomineralization of the entire bone cortex, which may have contributed to the increase in bone fractures. Mechanistically, osteoblastic VDR signaling suppressed calcium incorporation in bone by directly stimulating the transcription of genes encoding mineralization inhibitors. Ablation of skeletal Vdr signaling precluded this calcium transfer from bone to serum, leading to better preservation of bone mass and mineralization. These findings indicate that in mice, maintaining normocalcemia has priority over skeletal integrity, and that to minimize skeletal calcium storage, 1,25(OH)2D not only increases calcium release from bone, but also inhibits calcium incorporation in bone.This publication has 30 references indexed in Scilit:
- Genome-wide analysis of the VDR/RXR cistrome in osteoblast cells provides new mechanistic insight into the actions of the vitamin D hormoneThe Journal of Steroid Biochemistry and Molecular Biology, 2010
- A Downstream Intergenic Cluster of Regulatory Enhancers Contributes to the Induction of CYP24A1 Expression by 1α,25-Dihydroxyvitamin D3Published by Elsevier BV ,2010
- The biology and pathology of vitamin D control in boneJournal of Cellular Biochemistry, 2010
- Phosphorylation-dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavageJournal of Bone and Mineral Research, 2010
- Role of matrix vesicles in biomineralizationBiochimica et Biophysica Acta (BBA) - General Subjects, 2009
- Vitamin D and Human Health: Lessons from Vitamin D Receptor Null MiceEndocrine Reviews, 2008
- TRPV4-Mediated Calcium Influx Regulates Terminal Differentiation of OsteoclastsCell Metabolism, 2008
- Targeted Deletion of a Distant Transcriptional Enhancer of the Receptor Activator of Nuclear Factor-κB Ligand Gene Reduces Bone Remodeling and Increases Bone MassEndocrinology, 2007
- Effect of annual intramuscular vitamin D on fracture risk in elderly men and women a population-based, randomized, double-blind, placebo-controlled trialRheumatology, 2007
- BONE STRUCTURE AND METABOLISM IN CALCIUM-DEFICIENT RATSJournal of Endocrinology, 1960